{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T20:49:33Z","timestamp":1794516573219,"version":"4.9.1"},"reference-count":168,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1135720"],"award-info":[{"award-number":["APP1135720"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1105445"],"award-info":[{"award-number":["APP1105445"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001061","name":"Rebecca L. Cooper Medical Research Foundation","doi-asserted-by":"publisher","award":["#F2021971"],"award-info":[{"award-number":["#F2021971"]}],"id":[{"id":"10.13039\/501100001061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001061","name":"Rebecca L. Cooper Medical Research Foundation","doi-asserted-by":"publisher","award":["#PG2020645"],"award-info":[{"award-number":["#PG2020645"]}],"id":[{"id":"10.13039\/501100001061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Alzheimer\u2019s disease (AD) is a progressive neurodegenerative disorder leading to loss of cognitive abilities and ultimately, death. With no cure available, limited treatments mostly focus on symptom management. Identifying early changes in the disease course may provide new therapeutic targets to halt or reverse disease progression. Clinical studies have shown that cortical and hippocampal hyperactivity are a feature shared by patients in the early stages of disease, progressing to hypoactivity during later stages of neurodegeneration. The exact mechanisms causing neuronal excitability changes are not fully characterized; however, animal and cell models have provided insights into some of the factors involved in this phenotype. In this review, we summarize the evidence for neuronal excitability changes over the course of AD onset and progression and the molecular mechanisms underpinning these differences. Specifically, we discuss contributors to aberrant neuronal excitability, including abnormal levels of intracellular Ca\n                    <jats:sup>2+<\/jats:sup>\n                    and glutamate, pathological amyloid \u03b2 (A\u03b2) and tau, genetic risk factors, including\n                    <jats:italic>APOE<\/jats:italic>\n                    , and impaired inhibitory interneuron and glial function. In light of recent research indicating hyperexcitability could be a predictive marker of cognitive dysfunction, we further argue that the hyperexcitability phenotype could be leveraged to improve the diagnosis and treatment of AD, and present potential targets for future AD treatment development.\n                  <\/jats:p>","DOI":"10.1038\/s41398-022-02024-7","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:15:03Z","timestamp":1655856903000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":427,"title":["Neuronal hyperexcitability in Alzheimer\u2019s disease: what are the drivers behind this aberrant phenotype?"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1672-5378","authenticated-orcid":false,"given":"Helena","family":"Targa Dias Anastacio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Matosin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9241-8268","authenticated-orcid":false,"given":"Lezanne","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,22]]},"reference":[{"key":"2024_CR1","unstructured":"Prince M, Wimo A, Guerchet M, Gemma-Claire Ali M, Wu Y-T, Prina M, et al. World Alzheimer Report 2015\u2013The global impact of dementia: an analysis of prevalence, incidence, cost and trends. London: Alzheimer's Disease International; 2015."},{"key":"2024_CR2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jalz.2019.01.010","volume":"15","author":"Alzheimer\u2019s Association.","year":"2019","unstructured":"Alzheimer\u2019s Association. 2019 Alzheimer\u2019s disease facts and figures. Includes a special report on Alzheimer\u2019s detection in the primary care setting: connecting patients and physicians. Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc. 2019;15:321\u201387.","journal-title":"Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc"},{"key":"2024_CR3","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW. Alzheimer\u2019s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984;120:885\u201390.","journal-title":"Biochem Biophys Res Commun"},{"key":"2024_CR4","first-page":"89","volume":"17","author":"JP Brion","year":"1985","unstructured":"Brion JP, Couck AM, Passareiro E, Flament-Durand J. Neurofibrillary tangles of Alzheimer\u2019s disease: An immunohistochemical study. J Submicrosc Cytol. 1985;17:89\u201396.","journal-title":"J Submicrosc Cytol"},{"key":"2024_CR5","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1001\/archneur.55.3.294","volume":"55","author":"D Blacker","year":"1998","unstructured":"Blacker D, Tanzi RE. The genetics of Alzheimer disease: current status and future prospects. Arch Neurol. 1998;55:294\u20136.","journal-title":"Arch Neurol"},{"key":"2024_CR6","unstructured":"Bird TD. Alzheimer disease overview. GeneReviews; 1998."},{"key":"2024_CR7","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","volume":"43","author":"AM Saunders","year":"1993","unstructured":"Saunders AM, Strittmatter WJ, Schmechel D, St. George-Hyslop PH, Pericak-Vance MA, Joo SH, et al. Association of apolipoprotein E allele \u03f54 with late-onset familial and sporadic alzheimer\u2019s disease. Neurology. 1993;43:1467\u201372.","journal-title":"Neurology"},{"key":"2024_CR8","doi-asserted-by":"publisher","first-page":"10222","DOI":"10.1523\/JNEUROSCI.2250-06.2006","volume":"26","author":"KA Celone","year":"2006","unstructured":"Celone KA, Calhoun VD, Dickerson BC, Atri A, Chua EF, Miller SL, et al. Alterations in memory networks in mild cognitive impairment and Alzheimer\u2019s disease: An independent component analysis. J Neurosci. 2006;26:10222\u201331.","journal-title":"J Neurosci"},{"key":"2024_CR9","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1212\/01.wnl.0000171450.97464.49","volume":"65","author":"BC Dickerson","year":"2005","unstructured":"Dickerson BC, Salat DH, Greve DN, Chua EF, Rand-Giovannetti E, Rentz DM, et al. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology. 2005;65:404\u201311.","journal-title":"Neurology"},{"key":"2024_CR10","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.neurobiolaging.2006.08.008","volume":"28","author":"A H\u00e4m\u00e4l\u00e4inen","year":"2007","unstructured":"H\u00e4m\u00e4l\u00e4inen A, Pihlajam\u00e4ki M, Tanila H, H\u00e4nninen T, Niskanen E, Tervo S, et al. Increased fMRI responses during encoding in mild cognitive impairment. Neurobiol Aging. 2007;28:1889\u2013903.","journal-title":"Neurobiol Aging"},{"key":"2024_CR11","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1126\/science.1162844","volume":"321","author":"MA Busche","year":"2008","unstructured":"Busche MA, Eichhoff G, Adelsberger H, Abramowski D, Wiederhold KH, Haass C, et al. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer\u2019s disease. Science. 2008;321:1686\u20139.","journal-title":"Science"},{"key":"2024_CR12","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neuron.2014.10.024","volume":"84","author":"Z \u0160i\u0161kov\u00e1","year":"2014","unstructured":"\u0160i\u0161kov\u00e1 Z, Justus D, Kaneko H, Friedrichs D, Henneberg N, Beutel T, et al. Dendritic structural degeneration is functionally linked to cellular hyperexcitability in a mouse model of alzheimer\u2019s disease. Neuron. 2014;84:1023\u201333.","journal-title":"Neuron"},{"key":"2024_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep31450","volume":"6","author":"R Balez","year":"2016","unstructured":"Balez R, Steiner N, Engel M, Mu\u00f1oz SS, Lum JS, Wu Y, et al. Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer\u2019s disease. Sci Rep. 2016;6:1\u201316.","journal-title":"Sci Rep."},{"key":"2024_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.50333","volume":"8","author":"S Ghatak","year":"2019","unstructured":"Ghatak S, Dolatabadi N, Trudler D, Zhang X, Wu Y, Mohata M, et al. Mechanisms of hyperexcitability in alzheimer\u2019s disease hiPSC-derived neurons and cerebral organoids vs. Isogenic control. Elife. 2019;8:1\u201322.","journal-title":"Elife"},{"key":"2024_CR15","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1523\/JNEUROSCI.5215-08.2009","volume":"29","author":"R Minkeviciene","year":"2009","unstructured":"Minkeviciene R, Rheims S, Dobszay MB, Zilberter M, Hartikainen J, F\u00fcl\u00f6p L, et al. Amyloid \u03b2-induced neuronal hyperexcitability triggers progressive epilepsy. J Neurosci. 2009;29:3453\u201362.","journal-title":"J Neurosci"},{"key":"2024_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-019-0599-8","volume":"2","author":"R Gail Canter","year":"2019","unstructured":"Gail Canter R, Huang WC, Choi H, Wang J, Ashley Watson L, Yao CG, et al. 3D mapping reveals network-specific amyloid progression and subcortical susceptibility in mice. Commun Biol. 2019;2:1\u201312.","journal-title":"Commun Biol"},{"key":"2024_CR17","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1093\/brain\/awl089","volume":"129","author":"SS Bassett","year":"2006","unstructured":"Bassett SS, Yousem DM, Cristinzio C, Kusevic I, Yassa MA, Caffo BS, et al. Familial risk for Alzheimer\u2019s disease alters fMRI activation patterns. Brain. 2006;129:1229\u201339.","journal-title":"Brain"},{"key":"2024_CR18","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1056\/NEJM200008173430701","volume":"343","author":"SY Bookheimer","year":"2000","unstructured":"Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC, et al. Patterns of brain activation in people at risk for Alzheimer\u2019s disease. N. Engl J Med. 2000;343:450\u20136.","journal-title":"N. Engl J Med"},{"key":"2024_CR19","doi-asserted-by":"publisher","first-page":"7209","DOI":"10.1073\/pnas.0811879106","volume":"106","author":"N Filippini","year":"2009","unstructured":"Filippini N, MacIntosh BJ, Hough MG, Goodwin GM, Frisoni GB, Smith SM, et al. Distinct patterns of brain activity in young carriers of the APOE-\u03b54 allele. Proc Natl Acad Sci USA. 2009;106:7209\u201314.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024_CR20","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1212\/CON.0000000000000313","volume":"22","author":"RC Petersen","year":"2016","unstructured":"Petersen RC. Mild cognitive impairment. Contin Lifelong Learn Neurol. 2016;22:404\u201318.","journal-title":"Contin Lifelong Learn Neurol"},{"key":"2024_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1590\/S1980-57642014DN81000010","volume":"8","author":"DDC Miranda","year":"2014","unstructured":"Miranda DDC, Brucki SMD. Epilepsia em pacientes com doen\u00e7a de alzheimer: Uma revis\u00e3o sistem\u00e1tica. Dement e Neuropsychol. 2014;8:66\u201371.","journal-title":"Dement e Neuropsychol"},{"key":"2024_CR22","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/j.1528-1167.2006.00554.x","volume":"47","author":"JC Amatniek","year":"2006","unstructured":"Amatniek JC, Hauser WA, DelCastillo-Castaneda C, Jacobs DM, Marder K, Bell K, et al. Incidence and predictors of seizures in patients with Alzheimer\u2019s disease. Epilepsia. 2006;47:867\u201372.","journal-title":"Epilepsia"},{"key":"2024_CR23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1177\/089198879400700407","volume":"7","author":"MF Mendez","year":"1994","unstructured":"Mendez MF, Catanzaro P, Doss RC, Arguello R, Frey WH. Seizures in Alzheimer\u2019s disease: clinicopathologic study. J Geriatr Psychiatry Neurol. 1994;7:230\u20133.","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"2024_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.brainresbull.2011.11.017","volume":"88","author":"AM Hall","year":"2012","unstructured":"Hall AM, Roberson ED. Mouse models of Alzheimer\u2019s disease. Brain Res Bull. 2012;88:3\u201312.","journal-title":"Brain Res Bull"},{"key":"2024_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00401-016-1662-x","volume":"133","author":"E Drummond","year":"2017","unstructured":"Drummond E, Wisniewski T. Alzheimer\u2019s disease: experimental models and reality. Acta Neuropathologica. 2017;133:155\u201375.","journal-title":"Acta Neuropathologica"},{"key":"2024_CR26","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","volume":"55","author":"JJ Palop","year":"2007","unstructured":"Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer\u2019s disease. Neuron. 2007;55:697\u2013711.","journal-title":"Neuron"},{"key":"2024_CR27","doi-asserted-by":"publisher","first-page":"E1279","DOI":"10.1073\/pnas.1714409115","volume":"115","author":"C Lerdkrai","year":"2018","unstructured":"Lerdkrai C, Asavapanumas N, Brawek B, Kovalchuk Y, Mojtahedi N, Del Moral MO, et al. Intracellular Ca2+ stores control in vivo neuronal hyperactivity in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 2018;115:E1279\u201388.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024_CR28","doi-asserted-by":"publisher","first-page":"8740","DOI":"10.1073\/pnas.1206171109","volume":"109","author":"MA Busche","year":"2012","unstructured":"Busche MA, Chen X, Henning HA, Reichwald J, Staufenbiel M, Sakmann B, et al. Critical role of soluble amyloid- for early hippocampal hyperactivity in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 2012;109:8740\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep20119","volume":"6","author":"K Kam","year":"2016","unstructured":"Kam K, Duffy \u00c1M, Moretto J, LaFrancois JJ, Scharfman HE. Interictal spikes during sleep are an early defect in the Tg2576 mouse model of \u03b2-amyloid neuropathology. Sci Rep. 2016;6:1\u201316.","journal-title":"Sci Rep."},{"key":"2024_CR30","doi-asserted-by":"crossref","unstructured":"Bezzina C, Verret L, Juan C, Remaud J, Halley H, Rampon C, et al. Early onset of hypersynchronous network activity and expression of a marker of chronic seizures in the Tg2576 mouse model of Alzheimer\u2019s disease. PLoS ONE. 2015;10:e0119910.","DOI":"10.1371\/journal.pone.0119910"},{"key":"2024_CR31","doi-asserted-by":"publisher","first-page":"817","DOI":"10.2174\/1567205013666160129095508","volume":"13","author":"S Ziyatdinova","year":"2016","unstructured":"Ziyatdinova S, R\u00f6nnb\u00e4ck A, Gurevicius K, Miszczuk D, Graff C, Winblad B, et al. Increased epileptiform EEG activity and decreased seizure threshold in arctic APP transgenic mouse model of Alzheimer\u2019s disease. Curr Alzheimer Res. 2016;13:817\u201330.","journal-title":"Curr Alzheimer Res"},{"key":"2024_CR32","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.neuroscience.2010.10.027","volume":"171","author":"RC Klein","year":"2010","unstructured":"Klein RC, Mace BE, Moore SD, Sullivan PM. Progressive loss of synaptic integrity in human apolipoprotein E4 targeted replacement mice and attenuation by apolipoprotein E2. Neuroscience. 2010;171:1265\u201372.","journal-title":"Neuroscience"},{"key":"2024_CR33","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.nbd.2004.10.013","volume":"18","author":"C Wang","year":"2005","unstructured":"Wang C, Wilson WA, Moore SD, Mace BE, Maeda N, Schmechel DE, et al. Human apoE4-targeted replacement mice display synaptic deficits in the absence of neuropathology. Neurobiol Dis. 2005;18:390\u20138.","journal-title":"Neurobiol Dis"},{"key":"2024_CR34","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1016\/j.neurobiolaging.2014.02.019","volume":"35","author":"RC Klein","year":"2014","unstructured":"Klein RC, Acheson SK, Mace BE, Sullivan PM, Moore SD. Altered neurotransmission in the lateral amygdala in aged human apoE4 targeted replacement mice. Neurobiol Aging. 2014;35:2046\u201352.","journal-title":"Neurobiol Aging"},{"key":"2024_CR35","doi-asserted-by":"publisher","first-page":"R82","DOI":"10.1093\/hmg\/dds319","volume":"21","author":"JE Young","year":"2012","unstructured":"Young JE, Goldstein LSB. Alzheimer\u2019s disease in a dish: promises and challenges of human stem cell models. Hum Mol Genet. 2012;21:R82.","journal-title":"Hum Mol Genet"},{"key":"2024_CR36","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nature13800","volume":"515","author":"SH Choi","year":"2014","unstructured":"Choi SH, Kim YH, Hebisch M, Sliwinski C, Lee S, D\u2019Avanzo C, et al. A three-dimensional human neural cell culture model of Alzheimer\u2019s disease. Nature. 2014;515:274\u20138.","journal-title":"Nature"},{"key":"2024_CR37","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","volume":"98","author":"YT Lin","year":"2018","unstructured":"Lin YT, Seo J, Gao F, Feldman HM, Wen HL, Penney J, et al. APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types. Neuron. 2018;98:1141\u201354.e7.","journal-title":"Neuron"},{"key":"2024_CR38","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/s41593-018-0175-4","volume":"21","author":"J Park","year":"2018","unstructured":"Park J, Wetzel I, Marriott I, Dr\u00e9au D, D\u2019Avanzo C, Kim DY, et al. A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer\u2019s disease. Nat Neurosci. 2018;21:941\u201351.","journal-title":"Nat Neurosci"},{"key":"2024_CR39","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1212\/WNL.0b013e3181e3966e","volume":"74","author":"JL O\u2019Brien","year":"2010","unstructured":"O\u2019Brien JL, O\u2019Keefe BKM, Laviolette PS, Deluca AN, Blacker BD, Dickerson SBC, et al. Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline. Neurology. 2010;74:1969\u201376.","journal-title":"Neurology"},{"key":"2024_CR40","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/bies.201500004","volume":"37","author":"MA Busche","year":"2015","unstructured":"Busche MA, Konnerth A. Neuronal hyperactivity-A key defect in Alzheimer\u2019s disease? Bioessays. 2015;37:624\u201332.","journal-title":"Bioessays"},{"key":"2024_CR41","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.tins.2008.06.005","volume":"31","author":"I Bezprozvanny","year":"2008","unstructured":"Bezprozvanny I, Mattson MP. Neuronal calcium mishandling and the pathogenesis of Alzheimer\u2019s disease. Trends Neurosci. 2008;31:454\u201363.","journal-title":"Trends Neurosci"},{"key":"2024_CR42","doi-asserted-by":"publisher","first-page":"8566","DOI":"10.1523\/JNEUROSCI.1554-10.2010","volume":"30","author":"H Zhang","year":"2010","unstructured":"Zhang H, Sun S, Herreman A, De Strooper B, Bezprozvanny I. Neurobiology of disease role of presenilins in neuronal calcium homeostasis. J Neurosci. 2010;30:8566\u201380.","journal-title":"J Neurosci"},{"key":"2024_CR43","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.cell.2006.06.059","volume":"126","author":"H Tu","year":"2006","unstructured":"Tu H, Nelson O, Bezprozvanny A, Wang Z, Lee SF, Hao YH, et al. Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer\u2019s disease-linked mutations. Cell. 2006;126:981\u201393.","journal-title":"Cell"},{"key":"2024_CR44","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1083\/jcb.200706171","volume":"181","author":"KN Green","year":"2008","unstructured":"Green KN, Demuro A, Akbari Y, Hitt BD, Smith IF, Parker I, et al. SERCA pump activity is physiologically regulated by presenilin and regulates amyloid \u03b2 production. J Cell Biol. 2008;181:1107\u201316.","journal-title":"J Cell Biol"},{"key":"2024_CR45","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.neuron.2008.04.015","volume":"58","author":"K-H Cheung","year":"2008","unstructured":"Cheung K-H, Shineman D, M\u00fcller M, C\u00e1rdenas C, Mei L, Yang J, et al. Mechanism of Ca2+ disruption in Alzheimer\u2019s disease by presenilin regulation of InsP3 receptor channel gating. Neuron. 2008;58:871\u201383.","journal-title":"Neuron"},{"key":"2024_CR46","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/0896-6273(88)90162-6","volume":"1","author":"DW Choi","year":"1988","unstructured":"Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1988;1:623\u201334.","journal-title":"Neuron"},{"key":"2024_CR47","first-page":"819","volume":"121","author":"LC Jansson","year":"2014","unstructured":"Jansson LC, \u00c5kerman KE. The role of glutamate and its receptors in the proliferation, migration, differentiation and survival of neural progenitor cells. J Neural Transm 2014 1218. 2014;121:819\u201336.","journal-title":"J Neural Transm 2014 1218"},{"key":"2024_CR48","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1126\/science.164.3880.719","volume":"164","author":"JW Olney","year":"1969","unstructured":"Olney JW. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science. 1969;164:719\u201321.","journal-title":"Science"},{"key":"2024_CR49","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3233\/JAD-2007-11113","volume":"11","author":"CP Jacob","year":"2007","unstructured":"Jacob CP, Koutsilieri E, Bartl J, Neuen-Jacob E, Arzberger T, Zander N, et al. Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer\u2019s disease. J Alzheimer\u2019s Dis. 2007;11:97\u2013116.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"2024_CR50","doi-asserted-by":"publisher","first-page":"553.e1","DOI":"10.1016\/j.neurobiolaging.2010.03.008","volume":"32","author":"HA Scott","year":"2011","unstructured":"Scott HA, Gebhardt FM, Mitrovic AD, Vandenberg RJ, Dodd PR. Glutamate transporter variants reduce glutamate uptake in Alzheimer\u2019s disease. Neurobiol Aging. 2011;32:553.e1\u2013553.e11.","journal-title":"Neurobiol Aging"},{"key":"2024_CR51","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1097\/00005072-199708000-00008","volume":"56","author":"S Li","year":"1997","unstructured":"Li S, Mallory M, Alford M, Tanaka S, Masliah E. Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression. J Neuropathol Exp Neurol. 1997;56:901\u201311.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2024_CR52","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.neuint.2006.10.007","volume":"50","author":"HS Walton","year":"2007","unstructured":"Walton HS, Dodd PR. Glutamate-glutamine cycling in Alzheimer\u2019s disease. Neurochem Int. 2007;50:1052\u201366.","journal-title":"Neurochem Int"},{"key":"2024_CR53","doi-asserted-by":"publisher","first-page":"10540","DOI":"10.1073\/pnas.88.23.10540","volume":"88","author":"CD Smith","year":"1991","unstructured":"Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, et al. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci USA. 1991;88:10540\u20133.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024_CR54","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/BF00969698","volume":"20","author":"G Le Prince","year":"1995","unstructured":"Le Prince G, Delaere P, Fages C, Lefran\u00e7ois T, Touret M, Salanon M, et al. Glutamine synthetase (GS) expression is reduced in senile dementia of the Alzheimer type. Neurochem Res. 1995;20:859\u201362.","journal-title":"Neurochem Res"},{"key":"2024_CR55","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1326-8-16","volume":"8","author":"O Liraz","year":"2013","unstructured":"Liraz O, Boehm-Cagan A, Michaelson DM. ApoE4 induces A\u03b242, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice. Mol Neurodegener. 2013;8:16.","journal-title":"Mol Neurodegener"},{"key":"2024_CR56","doi-asserted-by":"crossref","unstructured":"Madeira C, Vargas-Lopes C, Brand\u00e3o CO, Reis T, Laks J, Panizzutti R, et al. Elevated glutamate and glutamine levels in the cerebrospinal fluid of patients with probable Alzheimer\u2019s disease and depression. Front Psychiatry. 2018;9:561.","DOI":"10.3389\/fpsyt.2018.00561"},{"key":"2024_CR57","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1176\/ajp.149.2.251","volume":"149","author":"N Pomara","year":"1992","unstructured":"Pomara N, Singh R, Deptula D, Chou JCY, Schwartz MB, LeWitt PA. Glutamate and other CSF amino acids in Alzheimer\u2019s disease. Am J Psychiatry. 1992;149:251\u20134.","journal-title":"Am J Psychiatry"},{"key":"2024_CR58","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1136\/jnnp.48.5.469","volume":"48","author":"CCT Smith","year":"1985","unstructured":"Smith CCT, Bowen DM, Francis PT, Snowden JS, Neary D. Putative amino acid transmitters in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer\u2019s dementia. J Neurol Neurosurg Psychiatry. 1985;48:469\u201371.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2024_CR59","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/BF02252924","volume":"2","author":"H Basun","year":"1990","unstructured":"Basun H, Forssell LG, Almkvist O, Cowburn RF, Ekl\u00f6f R, Winblad B, et al. Amino acid concentrations in cerebrospinal fluid and plasma in Alzheimer\u2019s disease and healthy control subjects. J Neural Transm Park Dis Dement Sect. 1990;2:295\u2013304.","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"2024_CR60","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s007020050016","volume":"107","author":"MA Kuiper","year":"2000","unstructured":"Kuiper MA, Teerlink T, Visser JJ, Bergmans PLM, Scheltens P, Wolters EC. L-glutamate, L-arginine and L-citrulline levels in cerebrospinal fluid of Parkinson\u2019s disease, multiple system atrophy, and Alzheimer\u2019s disease patients. J Neural Transm. 2000;107:183\u20139.","journal-title":"J Neural Transm"},{"key":"2024_CR61","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.celrep.2019.12.030","volume":"30","author":"JE Hanson","year":"2020","unstructured":"Hanson JE, Ma K, Elstrott J, Weber M, Saillet S, Khan AS, et al. GluN2A NMDA receptor enhancement improves brain oscillations, synchrony, and cognitive functions in Dravet syndrome and Alzheimer\u2019s disease models. Cell Rep. 2020;30:381\u201396.e4.","journal-title":"Cell Rep."},{"key":"2024_CR62","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.neuron.2014.03.030","volume":"82","author":"MP Parsons","year":"2014","unstructured":"Parsons MP, Raymond LA. Extrasynaptic NMDA receptor involvement in central nervous system disorders. Neuron. 2014;82:279\u201393.","journal-title":"Neuron"},{"key":"2024_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pgen.1005025","volume":"11","author":"Y Ping","year":"2015","unstructured":"Ping Y, Hahm E-T, Waro G, Song Q, Vo-Ba D-A, Licursi A, et al. Linking a\u03b242-induced hyperexcitability to neurodegeneration, learning and motor deficits, and a shorter lifespan in an Alzheimer\u2019s model. PLoS Genet. 2015;11:1\u201325.","journal-title":"PLoS Genet"},{"key":"2024_CR64","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3233\/JAD-2001-3507","volume":"3","author":"R Ho","year":"2001","unstructured":"Ho R, Ortiz D, Shea TB. Amyloid-\u03b2 promotes calcium influx and neurodegeneration via stimulation of L voltage-sensitive calcium channels rather than NMDA channels in cultured neurons. J Alzheimer\u2019s Dis. 2001;3:479\u201383.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"2024_CR65","doi-asserted-by":"crossref","unstructured":"Arispe N, Pollard HB, Rojas E. Giant multilevel cation channels formed by Alzheimer disease amyloid \u03b2- protein [A\u03b2P-(1-40)] in bilayer membranes. Proc Natl Acad Sci USA. 1993;90:10573\u20137.","DOI":"10.1073\/pnas.90.22.10573"},{"key":"2024_CR66","doi-asserted-by":"publisher","first-page":"E2518","DOI":"10.1073\/pnas.1306832110","volume":"110","author":"M Talantova","year":"2013","unstructured":"Talantova M, Sanz-Blasco S, Zhang X, Xia P, Akhtar MW, Okamoto SI, et al. A\u03b2 induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss. Proc Natl Acad Sci USA. 2013;110:E2518\u201327.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-1-2","volume":"1","author":"SZ Wu","year":"2004","unstructured":"Wu SZ, Bodles AM, Porter MM, Griffin WST, Basile AS, Barger SW. Induction of serine racemase expression and D-serine release from microglia by amyloid \u03b2-peptide. J Neuroinflammation. 2004;1:2.","journal-title":"J Neuroinflammation"},{"key":"2024_CR68","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.neuron.2009.05.012","volume":"62","author":"S Li","year":"2009","unstructured":"Li S, Hong S, Shepardson NE, Walsh DM, Shankar GM, Selkoe D. Soluble oligomers of amyloid \u03b2 protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron. 2009;62:788\u2013801.","journal-title":"Neuron"},{"key":"2024_CR69","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/jnr.490410416","volume":"41","author":"C Arias","year":"1995","unstructured":"Arias C, Arrieta I, Tapia R. \u03b2\u2010Amyloid peptide fragment 25\u201335 potentiates the calcium\u2010dependent release of excitatory amino acids from depolarized hippocampal slices. J Neurosci Res. 1995;41:561\u20136.","journal-title":"J Neurosci Res"},{"key":"2024_CR70","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0006-8993(97)00043-7","volume":"754","author":"A Parpura-Gill","year":"1997","unstructured":"Parpura-Gill A, Beitz D, Uemura E. The inhibitory effects of \u03b2-amyloid on glutamate and glucose uptakes by cultured astrocytes. Brain Res. 1997;754:65\u201371.","journal-title":"Brain Res"},{"key":"2024_CR71","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1126\/science.aay0198","volume":"365","author":"B Zott","year":"2019","unstructured":"Zott B, Simon MM, Hong W, Unger F, Chen-Engerer HJ, Frosch MP, et al. A vicious cycle of \u03b2 amyloid\u2212dependent neuronal hyperactivation. Science. 2019;365:559\u201365.","journal-title":"Science"},{"key":"2024_CR72","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.neuron.2005.10.028","volume":"48","author":"JR Cirrito","year":"2005","unstructured":"Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC, et al. Synaptic activity regulates interstitial fluid amyloid-\u03b2 levels in vivo. Neuron. 2005;48:913\u201322.","journal-title":"Neuron"},{"key":"2024_CR73","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.celrep.2015.04.017","volume":"11","author":"K Yamamoto","year":"2015","unstructured":"Yamamoto K, Tanei ZI, Hashimoto T, Wakabayashi T, Okuno H, Naka Y, et al. Chronic optogenetic activation augments A\u03b2 pathology in a mouse model of Alzheimer disease. Cell Rep. 2015;11:859\u201365.","journal-title":"Cell Rep."},{"key":"2024_CR74","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev-pathmechdis-012418-012936","volume":"14","author":"J G\u00f6tz","year":"2019","unstructured":"G\u00f6tz J, Halliday G, Nisbet RM. Molecular pathogenesis of the tauopathies. Annu Rev Pathol. 2019;14:239\u201361.","journal-title":"Annu Rev Pathol"},{"key":"2024_CR75","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3233\/JAD-170031","volume":"60","author":"AJ Beagle","year":"2017","unstructured":"Beagle AJ, Darwish SM, Ranasinghe KG, La AL, Karageorgiou E, Vossel KA. Relative incidence of seizures and myoclonus in Alzheimer\u2019s disease, dementia with lewy bodies, and frontotemporal dementia. J Alzheimer\u2019s Dis. 2017;60:211\u201323.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"2024_CR76","doi-asserted-by":"publisher","first-page":"12887","DOI":"10.1523\/JNEUROSCI.2107-13.2013","volume":"33","author":"SL DeVos","year":"2013","unstructured":"DeVos SL, Goncharoff DK, Chen G, Kebodeaux CS, Yamada K, Stewart FR, et al. Antisense reduction of tau in adult mice protects against seizures. J Neurosci. 2013;33:12887\u201397.","journal-title":"J Neurosci"},{"key":"2024_CR77","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1523\/JNEUROSCI.3191-12.2013","volume":"33","author":"JK Holth","year":"2013","unstructured":"Holth JK, Bomben VC, Graham Reed J, Inoue T, Younkin L, Younkin SG, et al. Tau loss attenuates neuronal network hyperexcitability in mouse and drosophila genetic models of epilepsy. J Neurosci. 2013;33:1651\u20139.","journal-title":"J Neurosci"},{"key":"2024_CR78","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1523\/JNEUROSCI.4152-10.2011","volume":"31","author":"ED Roberson","year":"2011","unstructured":"Roberson ED, Halabisky B, Yoo JW, Yao J, Chin J, Yan F, et al. Amyloid-\u03b2\/fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of alzheimer\u2019s disease. J Neurosci. 2011;31:700\u201311.","journal-title":"J Neurosci"},{"key":"2024_CR79","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","volume":"142","author":"LM Ittner","year":"2010","unstructured":"Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, et al. Dendritic function of tau mediates amyloid-\u03b2 toxicity in alzheimer\u2019s disease mouse models. Cell. 2010;142:387\u201397.","journal-title":"Cell"},{"key":"2024_CR80","doi-asserted-by":"publisher","first-page":"552","DOI":"10.15252\/embr.201541439","volume":"17","author":"JM Decker","year":"2016","unstructured":"Decker JM, Kr\u00fcger L, Sydow A, Dennissen FJ, Siskova Z, Mandelkow E, et al. The Tau\/A152T mutation, a risk factor for frontotemporal-spectrum disorders, leads to NR2B receptor-mediated excitotoxicity. EMBO Rep. 2016;17:552\u201369.","journal-title":"EMBO Rep."},{"key":"2024_CR81","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00401-012-1038-9","volume":"124","author":"JL Crimins","year":"2012","unstructured":"Crimins JL, Rocher AB, Luebke JI. Electrophysiological changes precede morphological changes to frontal cortical pyramidal neurons in the rTg4510 mouse model of progressive tauopathy. Acta Neuropathol. 2012;124:777\u201395.","journal-title":"Acta Neuropathol"},{"key":"2024_CR82","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1113\/jphysiol.2014.282889","volume":"594","author":"J Witton","year":"2016","unstructured":"Witton J, Staniaszek LE, Bartsch U, Randall AD, Jones MW, Brown JT. Disrupted hippocampal sharp-wave ripple-associated spike dynamics in a transgenic mouse model of dementia. J Physiol. 2016;594:4615\u201330.","journal-title":"J Physiol"},{"key":"2024_CR83","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1126\/science.1141736","volume":"316","author":"ED Roberson","year":"2007","unstructured":"Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, et al. Reducing endogenous tau ameliorates amyloid \u03b2-induced deficits in an Alzheimer\u2019s disease mouse model. Science. 2007;316:750\u20134.","journal-title":"Science"},{"key":"2024_CR84","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/embor.2013.15","volume":"14","author":"AM Pooler","year":"2013","unstructured":"Pooler AM, Phillips EC, Lau DHW, Noble W, Hanger DP. Physiological release of endogenous tau is stimulated by neuronal activity. EMBO Rep. 2013;14:389\u201394.","journal-title":"EMBO Rep."},{"key":"2024_CR85","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/nn.4328","volume":"19","author":"JW Wu","year":"2016","unstructured":"Wu JW, Hussaini SA, Bastille IM, Rodriguez GA, Mrejeru A, Rilett K, et al. Neuronal activity enhances tau propagation and tau pathology in vivo. Nat Neurosci. 2016;19:1085\u201392.","journal-title":"Nat Neurosci"},{"key":"2024_CR86","doi-asserted-by":"publisher","first-page":"6221","DOI":"10.1523\/JNEUROSCI.2552-14.2015","volume":"35","author":"AM Hall","year":"2015","unstructured":"Hall AM, Throesch BT, Buckingham SC, Markwardt SJ, Peng Y, Wang Q, et al. Tau-dependent Kv4.2 depletion and dendritic hyperexcitability in a mouse model of Alzheimer\u2019s disease. J Neurosci. 2015;35:6221\u201330.","journal-title":"J Neurosci"},{"key":"2024_CR87","doi-asserted-by":"publisher","first-page":"530","DOI":"10.15252\/embr.201541438","volume":"17","author":"S Maeda","year":"2016","unstructured":"Maeda S, Djukic B, Taneja P, Yu G-Q, Lo I, Davis A, et al. Expression of A152T human tau causes age-dependent neuronal dysfunction and loss in transgenic mice. EMBO Rep. 2016;17:530\u201351.","journal-title":"EMBO Rep."},{"key":"2024_CR88","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00401-017-1674-1","volume":"133","author":"RJ Hatch","year":"2017","unstructured":"Hatch RJ, Wei Y, Xia D, G\u00f6tz J. Hyperphosphorylated tau causes reduced hippocampal CA1 excitability by relocating the axon initial segment. Acta Neuropathol. 2017;133:717\u201330.","journal-title":"Acta Neuropathol"},{"key":"2024_CR89","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1093\/brain\/awz035","volume":"142","author":"P Marinkovi\u0107","year":"2019","unstructured":"Marinkovi\u0107 P, Blumenstock S, Goltstein PM, Korzhova V, Peters F, Knebl A, et al. In vivo imaging reveals reduced activity of neuronal circuits in a mouse tauopathy model. Brain. 2019;142:1051\u201362.","journal-title":"Brain"},{"key":"2024_CR90","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.nbd.2017.08.015","volume":"108","author":"SL Angulo","year":"2017","unstructured":"Angulo SL, Orman R, Neymotin SA, Liu L, Buitrago L, Cepeda-Prado E, et al. Tau and amyloid-related pathologies in the entorhinal cortex have divergent effects in the hippocampal circuit. Neurobiol Dis. 2017;108:261\u201376.","journal-title":"Neurobiol Dis"},{"key":"2024_CR91","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41593-018-0289-8","volume":"22","author":"MA Busche","year":"2019","unstructured":"Busche MA, Wegmann S, Dujardin S, Commins C, Schiantarelli J, Klickstein N, et al. Tau impairs neural circuits, dominating amyloid-\u03b2 effects, in Alzheimer models in vivo. Nat Neurosci. 2019;22:57\u201364.","journal-title":"Nat Neurosci"},{"key":"2024_CR92","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science. 1993;261:921\u20133.","journal-title":"Science"},{"key":"2024_CR93","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1126\/science.3283935","volume":"240","author":"RW Mahley","year":"1988","unstructured":"Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988;240:622\u201330.","journal-title":"Science"},{"key":"2024_CR94","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/00019442-200201000-00006","volume":"10","author":"AC Burggren","year":"2002","unstructured":"Burggren AC, Small GW, Sabb FW, Bookheimer SY. Specificity of brain activation patterns in people at genetic risk for Alzheimer disease. Am J Geriatr Psychiatry. 2002;10:44\u201351.","journal-title":"Am J Geriatr Psychiatry"},{"key":"2024_CR95","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1001\/archneur.62.12.1881","volume":"62","author":"AS Fleisher","year":"2005","unstructured":"Fleisher AS, Houston WS, Eyler LT, Frye S, Jenkins C, Thal LJ, et al. Identification of Alzheimer disease risk by functional magnetic resonance imaging. Arch Neurol. 2005;62:1881\u20138.","journal-title":"Arch Neurol"},{"key":"2024_CR96","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1176\/ajp.2006.163.9.1603","volume":"163","author":"HA Wishart","year":"2006","unstructured":"Wishart HA, Saykin AJ, Rabin LA, Santulli RB, Flashman LA, Guerin SJ, et al. Increased brain activation during working memory in cognitively intact adults with the APOE \u03b54 allele. Am J Psychiatry. 2006;163:1603\u201310.","journal-title":"Am J Psychiatry"},{"key":"2024_CR97","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.brainres.2012.05.048","volume":"1467","author":"JM Hunter","year":"2012","unstructured":"Hunter JM, Cirrito JR, Restivo JL, Kinley RD, Sullivan PM, Holtzman DM, et al. Emergence of a seizure phenotype in aged apolipoprotein epsilon 4 targeted replacement mice. Brain Res. 2012;1467:120\u201332.","journal-title":"Brain Res"},{"key":"2024_CR98","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/cns.12720","volume":"23","author":"G-Z Sun","year":"2017","unstructured":"Sun G-Z, He Y-C, Ma XK, Li S-T, Chen D-J, Gao M, et al. Hippocampal synaptic and neural network deficits in young mice carrying the human APOE4 gene. CNS Neurosci Ther. 2017;23:748\u201358.","journal-title":"CNS Neurosci Ther"},{"key":"2024_CR99","doi-asserted-by":"publisher","first-page":"10141","DOI":"10.1523\/JNEUROSCI.1054-16.2016","volume":"36","author":"C Lane-Donovan","year":"2016","unstructured":"Lane-Donovan C, Wong WM, Durakoglugil MS, Wasser CR, Jiang S, Xian X, et al. Genetic restoration of plasma apoe improves cognition and partially restores synaptic defects in ApoE-deficient mice. J Neurosci. 2016;36:10141\u201350.","journal-title":"J Neurosci"},{"key":"2024_CR100","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.stem.2009.10.015","volume":"5","author":"G Li","year":"2009","unstructured":"Li G, Bien-Ly N, Andrews-Zwilling Y, Xu Q, Bernardo A, Ring K, et al. GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice. Cell Stem Cell. 2009;5:634\u201345.","journal-title":"Cell Stem Cell"},{"key":"2024_CR101","doi-asserted-by":"publisher","first-page":"15317","DOI":"10.1523\/JNEUROSCI.4026-09.2009","volume":"29","author":"SB Dumanis","year":"2009","unstructured":"Dumanis SB, Tesoriero JA, Babus LW, Nguyen MT, Trotter JH, Ladu MJ, et al. ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo. J Neurosci. 2009;29:15317\u201322.","journal-title":"J Neurosci"},{"key":"2024_CR102","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.stemcr.2019.08.004","volume":"13","author":"H Konttinen","year":"2019","unstructured":"Konttinen H, Cabral-da-Silva MeC, Ohtonen S, Wojciechowski S, Shakirzyanova A, Caligola S, et al. PSEN1\u0394E9, APPswe, and APOE4 confer disparate phenotypes in human iPSC-derived microglia. Stem Cell Rep. 2019;13:669\u201383.","journal-title":"Stem Cell Rep"},{"key":"2024_CR103","doi-asserted-by":"crossref","unstructured":"Brookhouser N, Raman S, Frisch C, Srinivasan G, Brafman DA. APOE2 mitigates disease-related phenotypes in an isogenic hiPSC-based model of Alzheimer\u2019s disease. Mol Psychiatry. 2021;26:5715\u201332.","DOI":"10.1038\/s41380-021-01076-3"},{"key":"2024_CR104","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/0197-4580(96)00115-7","volume":"17","author":"J Rogers","year":"1996","unstructured":"Rogers J, Webster S, Lue LF, Brachova L, Civin WH, Emmerling M, et al. Inflammation and Alzheimer\u2019s disease pathogenesis. Neurobiol Aging. 1996;17:681\u20136.","journal-title":"Neurobiol Aging"},{"key":"2024_CR105","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1177\/1073858420912404","volume":"26","author":"L Ooi","year":"2020","unstructured":"Ooi L, Dottori M, Cook AL, Engel M, Gautam V, Grubman A, et al. If human brain organoids are the answer to understanding dementia, what are the questions? Neuroscientist. 2020;26:438\u201354.","journal-title":"Neuroscientist"},{"key":"2024_CR106","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","volume":"77","author":"CM Karch","year":"2015","unstructured":"Karch CM, Goate AM. Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry. 2015;77:43\u201351.","journal-title":"Biol Psychiatry"},{"key":"2024_CR107","doi-asserted-by":"publisher","first-page":"7605","DOI":"10.1158\/0008-5472.CAN-07-1100","volume":"67","author":"MY Chang","year":"2007","unstructured":"Chang MY, Boulden J, Katz JB, Wang L, Meyer TJ, Soler AP, et al. Bin1 ablation increases susceptibility to cancer during aging, particularly lung cancer. Cancer Res. 2007;67:7605\u201312.","journal-title":"Cancer Res"},{"key":"2024_CR108","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1083\/jcb.137.6.1355","volume":"137","author":"MH Butler","year":"1997","unstructured":"Butler MH, David C, Ochoa GC, Freyberg Z, Daniell L, Grabs D, et al. Amphiphysin II (SH3p9; BIN1), a member of the amphiphysin\/Rvs family, is concentrated in the cortical cytomatrix of axon initial segments and nodes of ranvier in brain and around T tubules in skeletal muscle. J Cell Biol. 1997;137:1355\u201367.","journal-title":"J Cell Biol"},{"key":"2024_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.57354","volume":"9","author":"Y Voskobiynyk","year":"2020","unstructured":"Voskobiynyk Y, Roth JR, Cochran JN, Rush T, Carullo NVN, Mesina JS, et al. Alzheimer\u2019s disease risk gene BIN1 induces Tau-dependent network hyperexcitability. Elife. 2020;9:1\u201325.","journal-title":"Elife"},{"key":"2024_CR110","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1152\/physrev.2001.81.2.871","volume":"81","author":"N Baumann","year":"2001","unstructured":"Baumann N, Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev. 2001;81:871\u2013927.","journal-title":"Physiol Rev"},{"key":"2024_CR111","doi-asserted-by":"crossref","unstructured":"Butt AM, De La Rocha IC, Rivera A. Oligodendroglial cells in alzheimer\u2019s disease. In: Verkhratsky A, Ho MS, Zorec R, Parpura V, editors. Advances in experimental medicine and biology. Singapore: Springer; 2019;325\u201333.","DOI":"10.1007\/978-981-13-9913-8_12"},{"key":"2024_CR112","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40478-018-0515-3","volume":"6","author":"SE Nasrabady","year":"2018","unstructured":"Nasrabady SE, Rizvi B, Goldman JE, Brickman AM. White matter changes in Alzheimer\u2019s disease: a focus on myelin and oligodendrocytes. Acta Neuropathol Commun. 2018;6:22.","journal-title":"Acta Neuropathol Commun"},{"key":"2024_CR113","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.tins.2012.11.008","volume":"36","author":"O Devinsky","year":"2013","unstructured":"Devinsky O, Vezzani A, Najjar S, De Lanerolle NC, Rogawski MA. Glia and epilepsy: excitability and inflammation. Trends Neurosci. 2013;36:174\u201384.","journal-title":"Trends Neurosci"},{"key":"2024_CR114","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/ana.20358","volume":"57","author":"C Dub\u00e9","year":"2005","unstructured":"Dub\u00e9 C, Vezzani A, Behrens M, Bartfai T, Baram TZ. Interleukin-1\u03b2 contributes to the generation of experimental febrile seizures. Ann Neurol. 2005;57:152.","journal-title":"Ann Neurol"},{"key":"2024_CR115","doi-asserted-by":"publisher","first-page":"10278","DOI":"10.1523\/JNEUROSCI.1301-17.2017","volume":"37","author":"I Bertani","year":"2017","unstructured":"Bertani I, Iori V, Trusel M, Maroso M, Foray C, Mantovani S, et al. Inhibition of IL-1\u03b2 signaling normalizes NMDA-dependent neurotransmission and reduces seizure susceptibility in a mouse model of Creutzfeldt-Jakob disease. J Neurosci. 2017;37:10278\u201389.","journal-title":"J Neurosci"},{"key":"2024_CR116","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1093\/brain\/awp177","volume":"132","author":"KM Rodgers","year":"2009","unstructured":"Rodgers KM, Hutchinson MR, Northcutt A, Maier SF, Watkins LR, Barth DS. The cortical innate immune response increases local neuronal excitability leading to seizures. Brain. 2009;132:2478.","journal-title":"Brain"},{"key":"2024_CR117","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/j.1528-1167.2006.00590.x","volume":"47","author":"T Ravizza","year":"2006","unstructured":"Ravizza T, Lucas SM, Balosso S, Bernardino L, Ku G, No\u00e9 F, et al. Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy. Epilepsia. 2006;47:1160\u20138.","journal-title":"Epilepsia"},{"key":"2024_CR118","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1093\/brain\/awn271","volume":"131","author":"S Balosso","year":"2008","unstructured":"Balosso S, Maroso M, Sanchez-Alavez M, Ravizza T, Frasca A, Bartfai T, et al. A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1\u03b2. Brain. 2008;131:3256.","journal-title":"Brain"},{"key":"2024_CR119","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1126\/science.1067859","volume":"295","author":"EC Beattie","year":"2002","unstructured":"Beattie EC, Stellwagen D, Morishita W, Bresnahan JC, Byeong KH, Von Zastrow M, et al. Control of synaptic strength by glial TNF\u03b1. Science. 2002;295:2282\u20135.","journal-title":"Science"},{"key":"2024_CR120","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.neuron.2011.02.003","volume":"69","author":"M Santello","year":"2011","unstructured":"Santello M, Bezzi P, Volterra A. TNF\u03b1 controls glutamatergic gliotransmission in the hippocampal dentate gyrus. Neuron. 2011;69:988\u20131001.","journal-title":"Neuron"},{"key":"2024_CR121","first-page":"3130","volume":"141","author":"F Frigerio","year":"2018","unstructured":"Frigerio F, Pasqualini G, Craparotta I, Marchini S, Van Vliet EA, Foerch P, et al. N-3 docosapentaenoic acid-derived protectin D1 promotes resolution of neuroinflammation and arrests epileptogenesis. Brain. 2018;141:3130\u201343.","journal-title":"Brain"},{"key":"2024_CR122","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/epi.13387","volume":"57","author":"S Lagarde","year":"2016","unstructured":"Lagarde S, Villeneuve N, Tr\u00e9buchon A, Kaphan E, Lepine A, McGonigal A, et al. Anti-tumor necrosis factor alpha therapy (adalimumab) in Rasmussen\u2019s encephalitis: an open pilot study. Epilepsia. 2016;57:956\u201366.","journal-title":"Epilepsia"},{"key":"2024_CR123","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1084\/jem.20041611","volume":"201","author":"K Takahashi","year":"2005","unstructured":"Takahashi K, Rochford CDP, Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med. 2005;201:647\u201357.","journal-title":"J Exp Med"},{"key":"2024_CR124","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41593-019-0433-0","volume":"22","author":"CEG Leyns","year":"2019","unstructured":"Leyns CEG, Gratuze M, Narasimhan S, Jain N, Koscal LJ, Jiang H, et al. TREM2 function impedes tau seeding in neuritic plaques. Nat Neurosci. 2019;22:1217.","journal-title":"Nat Neurosci"},{"key":"2024_CR125","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","volume":"90","author":"P Yuan","year":"2016","unstructured":"Yuan P, Condello C, Keene CD, Wang Y, Bird TD, Paul SM, et al. TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron. 2016;90:724.","journal-title":"Neuron"},{"key":"2024_CR126","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3389\/fimmu.2018.00698","volume":"9","author":"KM Lenz","year":"2018","unstructured":"Lenz KM, Nelson LH. Microglia and beyond: Innate immune cells as regulators of brain development and behavioral function. Front Immunol. 2018;9:698.","journal-title":"Front Immunol"},{"key":"2024_CR127","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1002\/glia.23961","volume":"69","author":"AD Umpierre","year":"2021","unstructured":"Umpierre AD, Wu LJ. How microglia sense and regulate neuronal activity. Glia. 2021;69:1637\u201353.","journal-title":"Glia"},{"key":"2024_CR128","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00401-013-1242-2","volume":"127","author":"B Brawek","year":"2014","unstructured":"Brawek B, Schwendele B, Riester K, Kohsaka S, Lerdkrai C, Liang Y, et al. Impairment of in vivo calcium signaling in amyloid plaque-associated microglia. Acta Neuropathol. 2014;127:495\u2013505.","journal-title":"Acta Neuropathol"},{"key":"2024_CR129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.56502","volume":"9","author":"AD Umpierre","year":"2020","unstructured":"Umpierre AD, Bystrom LL, Ying Y, Liu YU, Worrell G, Wu LJ. Microglial calcium signaling is attuned to neuronal activity in awake mice. Elife. 2020;9:1\u201324.","journal-title":"Elife"},{"key":"2024_CR130","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.devcel.2012.10.027","volume":"23","author":"Y Li","year":"2012","unstructured":"Li Y, Du XF, Liu CS, Wen ZL, Du JL. Reciprocal regulation between resting microglial dynamics and neuronal activity in vivo. Dev Cell. 2012;23:1189\u2013202.","journal-title":"Dev Cell"},{"key":"2024_CR131","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41586-020-2777-8","volume":"586","author":"A Badimon","year":"2020","unstructured":"Badimon A, Strasburger HJ, Ayata P, Chen X, Nair A, Ikegami A, et al. Negative feedback control of neuronal activity by microglia. Nature. 2020;586:417\u201323.","journal-title":"Nature"},{"key":"2024_CR132","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bbi.2020.06.028","volume":"89","author":"W Wu","year":"2020","unstructured":"Wu W, Li Y, Wei Y, Bosco DB, Xie M, Zhao MG, et al. Microglial depletion aggravates the severity of acute and chronic seizures in mice. Brain Behav Immun. 2020;89:245\u201355.","journal-title":"Brain Behav Immun"},{"key":"2024_CR133","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1523\/ENEURO.0088-18.2018","volume":"5","author":"R Akiyoshi","year":"2018","unstructured":"Akiyoshi R, Wake H, Kato D, Horiuchi H, Ono R, Ikegami A, et al. Microglia enhance synapse activity to promote local network synchronization. eNeuro. 2018;5:88\u2013106.","journal-title":"eNeuro"},{"key":"2024_CR134","first-page":"342","volume":"86","author":"DD Wang","year":"2008","unstructured":"Wang DD, Bordey A. The astrocyte odyssey. Prog Neurobiol. 2008;86:342\u201367.","journal-title":"Prog Neurobiol"},{"key":"2024_CR135","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.neuroscience.2004.06.008","volume":"129","author":"P Kofuji","year":"2004","unstructured":"Kofuji P, Newman EA. Potassium buffering in the central nervous system. Neuroscience. 2004;129:1043\u201354.","journal-title":"Neuroscience"},{"key":"2024_CR136","doi-asserted-by":"publisher","first-page":"980","DOI":"10.4103\/1673-5374.270295","volume":"15","author":"F Wang","year":"2020","unstructured":"Wang F, Qi X, Zhang J, Huang J. Astrocytic modulation of potassium under seizures. Neural Regeneration Res. 2020;15:980\u20137.","journal-title":"Neural Regeneration Res"},{"key":"2024_CR137","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.neuroscience.2009.01.023","volume":"159","author":"DM Wilcock","year":"2009","unstructured":"Wilcock DM, Vitek MP, Colton CA. Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer\u2019s disease. Neuroscience. 2009;159:1055.","journal-title":"Neuroscience"},{"key":"2024_CR138","doi-asserted-by":"publisher","first-page":"e81828","DOI":"10.1371\/journal.pone.0081828","volume":"8","author":"TM Pirttimaki","year":"2013","unstructured":"Pirttimaki TM, Codadu NK, Awni A, Pratik P, Nagel DA, Hill EJ, et al. \u03b17 nicotinic receptor-mediated astrocytic gliotransmitter release: A\u03b2 effects in a preclinical Alzheimer\u2019s mouse model. PLoS One. 2013;8:e81828.","journal-title":"PLoS One"},{"key":"2024_CR139","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bcp.2009.09.014","volume":"79","author":"A Buffo","year":"2010","unstructured":"Buffo A, Rolando C, Ceruti S. Astrocytes in the damaged brain: Molecular and cellular insights into their reactive response and healing potential. Biochem Pharm. 2010;79:77\u201389.","journal-title":"Biochem Pharm"},{"key":"2024_CR140","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nn.2535","volume":"13","author":"PI Ortinski","year":"2010","unstructured":"Ortinski PI, Dong J, Mungenast A, Yue C, Takano H, Watson DJ, et al. Selective induction of astrocytic gliosis generates deficits in neuronal inhibition. Nat Neurosci. 2010;13:584\u201391.","journal-title":"Nat Neurosci"},{"key":"2024_CR141","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nature12983","volume":"505","author":"A Kepecs","year":"2014","unstructured":"Kepecs A, Fishell G. Interneuron cell types are fit to function. Nature. 2014;505:318\u201326.","journal-title":"Nature"},{"key":"2024_CR142","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1093\/brain\/awt159","volume":"136","author":"JY Matsumoto","year":"2013","unstructured":"Matsumoto JY, Stead M, Kucewicz MT, Matsumoto AJ, Peters PA, Brinkmann BH, et al. Network oscillations modulate interictal epileptiform spike rate during human memory. Brain. 2013;136:2444\u201356.","journal-title":"Brain"},{"key":"2024_CR143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-017-01444-0","volume":"8","author":"T Nuriel","year":"2017","unstructured":"Nuriel T, Angulo SL, Khan U, Ashok A, Chen Q, Figueroa HY, et al. Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer\u2019s disease-like pathology. Nat Commun. 2017;8:1\u201314.","journal-title":"Nat Commun"},{"key":"2024_CR144","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.cell.2012.02.046","volume":"149","author":"L Verret","year":"2012","unstructured":"Verret L, Mann EO, Hang GB, Barth AMI, Cobos I, Ho K, et al. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in alzheimer model. Cell. 2012;149:708\u201321.","journal-title":"Cell"},{"key":"2024_CR145","doi-asserted-by":"publisher","first-page":"e1601068","DOI":"10.1126\/sciadv.1601068","volume":"3","author":"V Hamm","year":"2017","unstructured":"Hamm V, H\u00e9raud C, Bott JB, Herbeaux K, Strittmatter C, Mathis C, et al. Differential contribution of APP metabolites to early cognitive deficits in a TgCRND8 mouse model of Alzheimer\u2019s disease. Sci Adv. 2017;3:e1601068.","journal-title":"Sci Adv"},{"key":"2024_CR146","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.neuron.2018.02.029","volume":"98","author":"M Martinez-Losa","year":"2018","unstructured":"Martinez-Losa M, Tracy TE, Ma K, Verret L, Clemente-Perez A, Khan AS, et al. Nav1.1-overexpressing interneuron transplants restore brain rhythms and cognition in a mouse model of Alzheimer\u2019s disease. Neuron. 2018;98:75\u201389.","journal-title":"Neuron"},{"key":"2024_CR147","doi-asserted-by":"crossref","unstructured":"Chow CY, Chin YKY, Ma L, Undheim EAB, Herzig V, King GF. A selective NaV1.1 activator with potential for treatment of Dravet syndrome epilepsy. Biochem Pharmacol. 2020;181:113991.","DOI":"10.1016\/j.bcp.2020.113991"},{"key":"2024_CR148","doi-asserted-by":"publisher","first-page":"E8077","DOI":"10.1073\/pnas.1804764115","volume":"115","author":"KL Richards","year":"2018","unstructured":"Richards KL, Milligan CJ, Richardson RJ, Jancovski N, Grunnet M, Jacobson LH, et al. Selective NaV1.1 activation rescues Dravet syndrome mice from seizures and premature death. Proc Natl Acad Sci USA. 2018;115:E8077\u201385.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024_CR149","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA Deture","year":"2019","unstructured":"Deture MA, Dickson DW. The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegeneration. 2019;14:1\u201318.","journal-title":"Mol Neurodegeneration"},{"key":"2024_CR150","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.neuron.2012.03.023","volume":"74","author":"A Bakker","year":"2012","unstructured":"Bakker A, Krauss GL, Albert MS, Speck CL, Jones LR, Stark CE, et al. Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron. 2012;74:467\u201374.","journal-title":"Neuron"},{"key":"2024_CR151","doi-asserted-by":"crossref","unstructured":"Sanchez PE, Zhu L, Verret L, Vossel KA, Orr AG, Cirrito JR, et al. Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer\u2019s disease model. Proc Natl Acad Sci USA. 2012;109:E2895\u2013903.","DOI":"10.1073\/pnas.1121081109"},{"key":"2024_CR152","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1523\/JNEUROSCI.2531-15.2016","volume":"36","author":"P Yuan","year":"2016","unstructured":"Yuan P, Grutzendler J. Attenuation of \u03b2-amyloid deposition and neurotoxicity by chemogenetic modulation of neural activity. J Neurosci. 2016;36:632\u201341.","journal-title":"J Neurosci"},{"key":"2024_CR153","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/ana.24794","volume":"80","author":"KA Vossel","year":"2016","unstructured":"Vossel KA, Ranasinghe KG, Beagle AJ, Mizuiri D, Honma SM, Dowling AF, et al. Incidence and impact of subclinical epileptiform activity in Alzheimer\u2019s disease. Ann Neurol. 2016;80:858\u201370.","journal-title":"Ann Neurol"},{"key":"2024_CR154","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1007\/s12035-017-0392-y","volume":"55","author":"D Do-Ha","year":"2018","unstructured":"Do-Ha D, Buskila Y, Ooi L. Impairments in motor neurons, interneurons and astrocytes contribute to hyperexcitability in ALS: underlying mechanisms and paths to therapy. Mol Neurobiol. 2018;55:1410\u20138.","journal-title":"Mol Neurobiol"},{"key":"2024_CR155","doi-asserted-by":"publisher","first-page":"E8316","DOI":"10.1073\/pnas.1605210113","volume":"113","author":"M Lalancette-Hebert","year":"2016","unstructured":"Lalancette-Hebert M, Sharma A, Lyashchenko AK, Shneider NA. Gamma motor neurons survive and exacerbate alpha motor neuron degeneration in ALS. Proc Natl Acad Sci USA. 2016;113:E8316\u201325.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024_CR156","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature06447","volume":"451","author":"AR Houweling","year":"2008","unstructured":"Houweling AR, Brecht M. Behavioural report of single neuron stimulation in somatosensory cortex. Nature. 2008;451:65\u20138.","journal-title":"Nature"},{"key":"2024_CR157","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/nature02266","volume":"427","author":"M Brecht","year":"2004","unstructured":"Brecht M, Schneider M, Sakmann B, Margie TW. Whisker movements evoked by stimulation of single pyramidal cells in rat motor cortex. Nature. 2004;427:704\u201310.","journal-title":"Nature"},{"key":"2024_CR158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms1783","volume":"3","author":"C Grienberger","year":"2012","unstructured":"Grienberger C, Rochefort NL, Adelsberger H, Henning HA, Hill DN, Reichwald J, et al. Staged decline of neuronal function in vivo in an animal model of Alzheimer\u2019s disease. Nat Commun. 2012;3:1\u201310.","journal-title":"Nat Commun"},{"key":"2024_CR159","doi-asserted-by":"publisher","first-page":"6877","DOI":"10.1523\/JNEUROSCI.1744-05.2005","volume":"25","author":"IA Wilson","year":"2005","unstructured":"Wilson IA, Ikonen S, Gallagher M, Eichenbaum H, Tanila H. Age-associated alterations of hippocampal place cells are subregion specific. J Neurosci. 2005;25:6877.","journal-title":"J Neurosci"},{"key":"2024_CR160","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1126\/science.aal3222","volume":"356","author":"D Gosselin","year":"2017","unstructured":"Gosselin D, Skola D, Coufal NG, Holtman IR, Schlachetzki JCM, Sajti E, et al. An environment-dependent transcriptional network specifies human microglia identity. Science. 2017;356:1248\u201359.","journal-title":"Science"},{"key":"2024_CR161","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.neuron.2017.04.043","volume":"94","author":"CJ Bohlen","year":"2017","unstructured":"Bohlen CJ, Bennett FC, Tucker AF, Collins HY, Mulinyawe SB, Barres BA. Diverse requirements for microglial survival, specification, and function revealed by defined-medium cultures. Neuron. 2017;94:759.","journal-title":"Neuron"},{"key":"2024_CR162","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1016\/j.biomaterials.2012.03.001","volume":"33","author":"AI Astashkina","year":"2012","unstructured":"Astashkina AI, Mann BK, Prestwich GD, Grainger DW. Comparing predictive drug nephrotoxicity biomarkers in kidney 3-D primary organoid culture and immortalized cell lines. Biomaterials. 2012;33:4712\u201321.","journal-title":"Biomaterials"},{"key":"2024_CR163","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13024-018-0258-4","volume":"13","author":"EGZ Centeno","year":"2018","unstructured":"Centeno EGZ, Cimarosti H, Bithell A. 2D versus 3D human induced pluripotent stem cell-derived cultures for neurodegenerative disease modelling. Mol Neurodegener. 2018;13:27.","journal-title":"Mol Neurodegener"},{"key":"2024_CR164","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nature22047","volume":"545","author":"G Quadrato","year":"2017","unstructured":"Quadrato G, Nguyen T, Macosko EZ, Sherwood JL, Yang SM, Berger DR, et al. Cell diversity and network dynamics in photosensitive human brain organoids. Nature. 2017;545:48\u201353.","journal-title":"Nature"},{"key":"2024_CR165","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/j.stemcr.2017.10.016","volume":"9","author":"M Oksanen","year":"2017","unstructured":"Oksanen M, Petersen AJ, Naumenko N, Puttonen K, Lehtonen \u0160, Gubert Oliv\u00e9 M, et al. PSEN1 mutant iPSC-derived model reveals severe astrocyte pathology in Alzheimer\u2019s disease. Stem Cell Rep. 2017;9:1885\u201397.","journal-title":"Stem Cell Rep"},{"key":"2024_CR166","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1073\/pnas.0611513104","volume":"104","author":"A Bernareggi","year":"2007","unstructured":"Bernareggi A, Due\u00f1as Z, Reyes-Ruiz JM, Ruzzier F, Miledi R. Properties of glutamate receptors of Alzheimer\u2019s disease brain transplanted to frog oocytes. Proc Natl Acad Sci USA. 2007;104:2956.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024_CR167","doi-asserted-by":"publisher","first-page":"10071","DOI":"10.1073\/pnas.1204606109","volume":"109","author":"A Limon","year":"2012","unstructured":"Limon A, Reyes-Ruiz JM, Miledi R. Loss of functional GABA A receptors in the Alzheimer diseased brain. Proc Natl Acad Sci USA. 2012;109:10071\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024_CR168","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1073\/pnas.0308224100","volume":"101","author":"R Miledi","year":"2004","unstructured":"Miledi R, Due\u00f1as Z, Martinez-Torres A, Kawas CH, Eusebi F. From the cover: microtransplantation of functional receptors and channels from the Alzheimer\u2019s brain to frog oocytes. Proc Natl Acad Sci USA. 2004;101:1760.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02024-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02024-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02024-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T14:41:50Z","timestamp":1669214510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02024-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,22]]},"references-count":168,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2024"],"URL":"https:\/\/doi.org\/10.1038\/s41398-022-02024-7","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,22]]},"assertion":[{"value":"17 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"257"}}